- Talanx has increased its forecast for full-year net income, now expecting it to exceed €1.90 billion, previously projected at over €1.70 billion.
- The consensus estimate for the 2025 net income is set at €2.06 billion; however, Talanx anticipates it will exceed €2.10 billion.
- For the first nine months, Talanx reported a 12% increase in insurance revenue, amounting to €36.0 billion.
- Group net income saw a significant rise of 24%, reaching €1,592 million.
- The return on equity achieved was a robust 19.4%.
- Analyst recommendations include 3 buys, 5 holds, and 2 sells for Talanx.
A look at Talanx Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Talanx is showing a positive long-term outlook. With strong scores in Dividend, Growth, and Momentum, the company seems to be well-positioned for future success. The company’s focus on providing insurance and financial services globally has helped it maintain resilience despite market fluctuations, as indicated by its score in Resilience. Although there is room for improvement in the Value factor, the overall outlook for Talanx appears to be promising.
Talanx AG, a holding company in the insurance and financial services sector, continues to expand its reach and offerings to cater to retail, commercial, private, and industrial clients worldwide. With a solid foundation in place, Talanx’s emphasis on dividends, growth opportunities, and market momentum underscores its commitment to long-term sustainability and growth in the industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
